Hastha Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-06-2024
- Paid Up Capital ₹ 0.13 M
as on 26-06-2024
- Company Age 24 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 18.00 Cr
as on 26-06-2024
- Revenue %
(FY 2020)
- Profit -137.12%
(FY 2020)
- Ebitda -296.46%
(FY 2020)
- Net Worth -0.47%
(FY 2020)
- Total Assets 103.17%
(FY 2020)
About Hastha Bio-Tech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.13 M.
The company has closed loans amounting to ₹18.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Venkata Indukuri and Jhansi Byrraju serve as directors at the Company.
- CIN/LLPIN
U15142TG2000PTC033699
- Company No.
033699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2000
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hastha Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Indukuri  | Director | 21-Mar-2017 | Current |
| Jhansi Byrraju | Director | 25-Feb-2000 | Current |
Financial Performance of Hastha Bio-Tech.
Hastha Bio-Tech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 137.12% decrease in profit. The company's net worth dipped by a decrease of 0.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hastha Bio-Tech?
In 2018, Hastha Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pushyami Agro-Farms Private LimitedActive 20 years 2 daysVenkata Indukuri and Jhansi Byrraju are mutual person
- Mandaragiri Greenfields Private LimitedActive 21 years 5 months
Venkata Indukuri and Jhansi Byrraju are mutual person
- Continental Thermits Pvt LtdActive 43 years 11 months
Venkata Indukuri and Jhansi Byrraju are mutual person
- Srsr Estates Private LimitedActive 29 years 9 months
Venkata Indukuri and Jhansi Byrraju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 08 Feb 2010 | ₹18.00 Cr | Satisfied |
How Many Employees Work at Hastha Bio-Tech?
Unlock and access historical data on people associated with Hastha Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hastha Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hastha Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
